Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Hyperprolactinaemia with amisulpride (CROSBI ID 170771)

Prilog u časopisu | kratko priopćenje

Ružić, Klementina ; Grahovac, Tanja ; Graovac, Mirjana ; Dadić-Hero, Elizabeta ; Šepić-Grahovac, Dubravka ; Sabljić, Vladimir Hyperprolactinaemia with amisulpride // Psychiatria Danubina, 23 (2011), 1; 92-94

Podaci o odgovornosti

Ružić, Klementina ; Grahovac, Tanja ; Graovac, Mirjana ; Dadić-Hero, Elizabeta ; Šepić-Grahovac, Dubravka ; Sabljić, Vladimir

engleski

Hyperprolactinaemia with amisulpride

Psychopharmaca are used in treatment of psychiatric illnesses and disorders, among other therapeutic possibilities. The choice of the psychopharmaca is determined by the specific psychopathology of the patient, within the diagnostic categories, according to the current classification of diseases and disorders. With the advances in pharmaco industry, the range of drugs used in the everyday clinical practice is occurring at a very rapid pace. Antipsychotic medications are used in treatment of mainly psychotic disorders. However, the new generation of antipsychotics, due to their specific receptor affinities, is sometimes used in treatment of affective disorders as well. We are reporting a case of a female patient who was hospitalized several times. Amisulpride was introduced in the treatment and due to a series of unfortunate events and changes that followed (i. e. frequent hospitalizations and changes of therapists, different mental institutions) dose of amisulpride was gradually increased to its antipsychotic doses, which did not help achieve therapeutic benefits, but serious side effects.

mixed anxiety; depressive disorder; amisulpride; hyperprolactinaemia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (1)

2011.

92-94

objavljeno

0353-5053

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost